Group One Trading’s LAVA Therapeutics LVTX Stock Holding History

Group One Trading’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,900	Closed	-$36.3K	–	7163
2024 Q1	$36.3K	Buy	+10,900	New	+$24K	﹤0.01%	4973

Group One Trading's LVTX Position: Q1 2024 in Review

Group One Trading sold out of LAVA Therapeutics (LVTX) in Q1 2024, closing a stake of 100 shares — an estimated $220 sold.

Group One Trading first reported a position in LVTX in Q2 2023 and held it in 3 quarters. The position peaked at $203 in Q2 2023. 20 funds tracked by Wall St. Rank hold LVTX as of Q1 2024.

Group One Trading reported no remaining LAVA Therapeutics position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 100 LAVA Therapeutics shares in Q1 2024, an estimated $220.
Group One Trading first reported a position in LAVA Therapeutics in Q2 2023 and held it in 3 quarters.
Group One Trading's LAVA Therapeutics position peaked at $203 in Q2 2023.
20 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.